Peng Wei-Xia, Shibata Tatsuhiro, Katoh Hiroto, Kokubu Akiko, Matsuno Yoshihiro, Asamura Hisao, Tsuchiya Ryosuke, Kanai Yae, Hosoda Fumie, Sakiyama Tokuki, Ohki Misao, Imoto Issei, Inazawa Johji, Hirohashi Setsuo
Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Cancer Sci. 2005 Oct;96(10):661-7. doi: 10.1111/j.1349-7006.2005.00092.x.
We examined a large number of primary high-grade neuroendocrine tumors of the lung (10 small cell lung carcinomas and 31 large cell neuroendocrine carcinomas) by using array-based comparative genomic hybridization using microarrays spotted with 800 bacterial artificial chromosome clones containing tumor-related genes from throughout the human genome. We identified the genome-wide copy number alteration profiles of these tumors, including recurrent amplifications located at 2q21.2, 3q21-27, 3q26, 3q27-29, 5p14.2, 5p13, 7q21.1, 8q21, and 8q24 and homozygous deletions at 1p36, 4p16, 4p16.3, 9p21.3, 9p21, 19p13.3, and 20q13. Our results revealed that small cell lung carcinomas and large cell neuroendocrine carcinomas have multiple characteristic chromosomal alterations in common, but that distinctive alterations also exist between the two subtypes. Moreover, we found that the two subtypes undergo different processes of accumulating these genetic alterations during tumor development. By comparing the genetic profiles with the clinicopathological features, we discovered many chromosomal loci whose alterations were significantly associated with clinical stage and patient prognosis. These results will be valuable for evaluating clinical status, including patient prognosis, and for identifying novel molecular targets for effective therapies.
我们使用基于微阵列的比较基因组杂交技术,检测了大量原发性肺高级别神经内分泌肿瘤(10例小细胞肺癌和31例大细胞神经内分泌癌),该微阵列点样有800个细菌人工染色体克隆,这些克隆包含来自整个人类基因组的肿瘤相关基因。我们确定了这些肿瘤的全基因组拷贝数改变图谱,包括位于2q21.2、3q21 - 27、3q26、3q27 - 29、5p14.2、5p13、7q21.1、8q21和8q24的反复扩增,以及位于1p36、4p16、4p16.3、9p21.3、9p21、19p13.3和20q13的纯合缺失。我们的结果显示,小细胞肺癌和大细胞神经内分泌癌有多个共同的特征性染色体改变,但这两种亚型之间也存在独特的改变。此外,我们发现这两种亚型在肿瘤发生过程中积累这些基因改变的过程不同。通过将基因图谱与临床病理特征进行比较,我们发现许多染色体位点的改变与临床分期和患者预后显著相关。这些结果对于评估临床状况(包括患者预后)以及确定有效治疗的新分子靶点具有重要价值。